Interaction of Human Immunodeficiency Virus Type 1 Tat with a Unique Site of TFIID Inhibits Negative Cofactor Dr1 and Stabilizes the TFIID-TFIIA Complex

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1996 Aug 1

PMID 8764062

Citations 20

Authors

F Kashanchi

S N Khleif

J F Duvall

M R Sadaie

M F Radonovich

M Cho

M A Martin

S Y Chen

R Weinmann

J N Brady

Affiliations

Soon will be listed here.

Abstract

We have previously reported the direct physical interaction between the human immunodeficiency virus (HIV) type I Tat protein and the basal transcription factor TBP/TFIID. Affinity chromatography demonstrated that wild-type Tat, but not a transactivation mutant of Tat, was capable of depleting TBP/TFIID from cell extracts. These experiments represented the first demonstration of a basal transcription factor that binds, in an activation-dependent manner, to Tat. We now report that the Tat-TBP interaction can be detected in HIV type 1-infected cells. The domain of TBP interacting with Tat has been mapped from amino acids 163 to 196 by using deletion and site-specific mutants of TBP. This domain of TBP, which includes the HI and S2 domains, is distinct from the H2 binding site for other activator proteins, such as E1A. The interaction of Tat with TFIID regulates the binding of accessory proteins to TFIID. Tat stabilizes the interaction of TFIID with TFIIA in a gel shift assay. In addition, Tat competes for Dr1 interaction with TBP. Our results suggest that the basal transcription factor TBP/TFIID represents an important regulatory molecule in HIV transcription.

Citing Articles

Involvement of Human Cellular Proteins and Structures in Realization of the HIV Life Cycle: A Comprehensive Review, 2024.

Schemelev A, Davydenko V, Ostankova Y, Reingardt D, Serikova E, Zueva E Viruses. 2024; 16(11).

PMID: 39599797 PMC: 11599013. DOI: 10.3390/v16111682.

Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.

Delannoy A, Poirier M, Bell B Viruses. 2019; 11(3).

PMID: 30889861 PMC: 6466452. DOI: 10.3390/v11030269.

Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.

Welch J, Kaddour H, Schlievert P, Stapleton J, Okeoma C J Virol. 2018; 92(21).

PMID: 30111566 PMC: 6189507. DOI: 10.1128/JVI.00731-18.

A mini-review of TAT-MyoD fused proteins: state of the art and problems to solve.

Patruno M, Melotti L, Gomiero C, Sacchetto R, Topel O, Martinello T Eur J Transl Myol. 2018; 27(4):6039.

PMID: 29299217 PMC: 5745379. DOI: 10.4081/ejtm.2017.6039.

Tat-MyoD fused proteins, together with C2c12 conditioned medium, are able to induce equine adult mesenchimal stem cells towards the myogenic fate.

Patruno M, Gomiero C, Sacchetto R, Topel O, Negro A, Martinello T Vet Res Commun. 2017; 41(3):211-217.

PMID: 28589421 DOI: 10.1007/s11259-017-9692-y.

References

Sato H, Orenstein J, Dimitrov D, Martin M . Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology. 1992; 186(2):712-24. DOI: 10.1016/0042-6822(92)90038-q. View

Comai L, Tanese N, Tjian R . The TATA-binding protein and associated factors are integral components of the RNA polymerase I transcription factor, SL1. Cell. 1992; 68(5):965-76. DOI: 10.1016/0092-8674(92)90039-f. View

Inostroza J, Mermelstein F, Ha I, Lane W, Reinberg D . Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell. 1992; 70(3):477-89. DOI: 10.1016/0092-8674(92)90172-9. View

Kashanchi F, Duvall J, Brady J . Electroporation of viral transactivator proteins into lymphocyte suspension cells. Nucleic Acids Res. 1992; 20(17):4673-4. PMC: 334210. DOI: 10.1093/nar/20.17.4673. View

Kassavetis G, Joazeiro C, Pisano M, Geiduschek E, Colbert T, Hahn S . The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB. Cell. 1992; 71(6):1055-64. DOI: 10.1016/0092-8674(92)90399-w. View

Bohan C, Kashanchi F, Ensoli B, Buonaguro L, Brady J . Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr. 1992; 2(4):391-407. PMC: 6057369. View

Chang L, McNulty E, Martin M . Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms. J Virol. 1993; 67(2):743-52. PMC: 237426. DOI: 10.1128/JVI.67.2.743-752.1993. View

Ohana B, Moore P, Ruben S, Southgate C, Green M, Rosen C . The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc Natl Acad Sci U S A. 1993; 90(1):138-42. PMC: 45615. DOI: 10.1073/pnas.90.1.138. View

Gruda M, Zabolotny J, Xiao J, Davidson I, Alwine J . Transcriptional activation by simian virus 40 large T antigen: interactions with multiple components of the transcription complex. Mol Cell Biol. 1993; 13(2):961-9. PMC: 358980. DOI: 10.1128/mcb.13.2.961-969.1993. View

10.

Hernandez N . TBP, a universal eukaryotic transcription factor?. Genes Dev. 1993; 7(7B):1291-308. DOI: 10.1101/gad.7.7b.1291. View

11.

Boyer T, Berk A . Functional interaction of adenovirus E1A with holo-TFIID. Genes Dev. 1993; 7(9):1810-23. DOI: 10.1101/gad.7.9.1810. View

12.

Manley J, Fire A, Cano A, Sharp P, Gefter M . DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. Proc Natl Acad Sci U S A. 1980; 77(7):3855-9. PMC: 349725. DOI: 10.1073/pnas.77.7.3855. View

13.

Dignam J, Martin P, Shastry B, Roeder R . Eukaryotic gene transcription with purified components. Methods Enzymol. 1983; 101:582-98. DOI: 10.1016/0076-6879(83)01039-3. View

14.

Luse D, Kochel T, Kuempel E, Coppola J, Cai H . Transcription initiation by RNA polymerase II in vitro. At least two nucleotides must be added to form a stable ternary complex. J Biol Chem. 1987; 262(1):289-97. View

15.

Cai H, Luse D . Transcription initiation by RNA polymerase II in vitro. Properties of preinitiation, initiation, and elongation complexes. J Biol Chem. 1987; 262(1):298-304. View

16.

Reinberg D, Roeder R . Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE. J Biol Chem. 1987; 262(7):3310-21. View

17.

HAWLEY D, Roeder R . Functional steps in transcription initiation and reinitiation from the major late promoter in a HeLa nuclear extract. J Biol Chem. 1987; 262(8):3452-61. View

18.

Vogel J, Hinrichs S, Reynolds R, Luciw P, Jay G . The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature. 1988; 335(6191):606-11. DOI: 10.1038/335606a0. View

19.

Buratowski S, Hahn S, Guarente L, Sharp P . Five intermediate complexes in transcription initiation by RNA polymerase II. Cell. 1989; 56(4):549-61. DOI: 10.1016/0092-8674(89)90578-3. View

20.

Saltzman A, Weinmann R . Promoter specificity and modulation of RNA polymerase II transcription. FASEB J. 1989; 3(6):1723-33. DOI: 10.1096/fasebj.3.6.2649403. View